nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—ABCB1—colon cancer	0.811	1	CbGaD
Terazosin—Doxazosin—ABCB1—colon cancer	0.00179	0.52	CrCbGaD
Terazosin—Prazosin—ABCB1—colon cancer	0.00165	0.48	CrCbGaD
Terazosin—Libido decreased—Capecitabine—colon cancer	0.000987	0.00532	CcSEcCtD
Terazosin—Urinary tract infection—Fluorouracil—colon cancer	0.000981	0.00529	CcSEcCtD
Terazosin—Conjunctivitis—Fluorouracil—colon cancer	0.000981	0.00529	CcSEcCtD
Terazosin—Atrial fibrillation—Capecitabine—colon cancer	0.000966	0.00521	CcSEcCtD
Terazosin—Epistaxis—Fluorouracil—colon cancer	0.000952	0.00513	CcSEcCtD
Terazosin—Rhinitis—Irinotecan—colon cancer	0.000949	0.00511	CcSEcCtD
Terazosin—Sinusitis—Fluorouracil—colon cancer	0.000947	0.00511	CcSEcCtD
Terazosin—Arthritis—Capecitabine—colon cancer	0.000942	0.00508	CcSEcCtD
Terazosin—Cardiac failure—Capecitabine—colon cancer	0.000938	0.00506	CcSEcCtD
Terazosin—Cerebrovascular accident—Capecitabine—colon cancer	0.000934	0.00504	CcSEcCtD
Terazosin—Osteoarthritis—Capecitabine—colon cancer	0.000915	0.00494	CcSEcCtD
Terazosin—Pain in extremity—Capecitabine—colon cancer	0.000915	0.00494	CcSEcCtD
Terazosin—Visual impairment—Irinotecan—colon cancer	0.000912	0.00492	CcSEcCtD
Terazosin—Rhinitis—Fluorouracil—colon cancer	0.000909	0.0049	CcSEcCtD
Terazosin—Disturbance in sexual arousal—Capecitabine—colon cancer	0.000908	0.0049	CcSEcCtD
Terazosin—Migraine—Capecitabine—colon cancer	0.000901	0.00486	CcSEcCtD
Terazosin—Pharyngitis—Fluorouracil—colon cancer	0.000899	0.00485	CcSEcCtD
Terazosin—Face oedema—Capecitabine—colon cancer	0.000884	0.00477	CcSEcCtD
Terazosin—Arrhythmia—Irinotecan—colon cancer	0.000845	0.00456	CcSEcCtD
Terazosin—Orthostatic hypotension—Capecitabine—colon cancer	0.000836	0.00451	CcSEcCtD
Terazosin—Hypokalaemia—Capecitabine—colon cancer	0.000833	0.00449	CcSEcCtD
Terazosin—Nasopharyngitis—Capecitabine—colon cancer	0.000819	0.00441	CcSEcCtD
Terazosin—Back pain—Vincristine—colon cancer	0.000818	0.00441	CcSEcCtD
Terazosin—Flatulence—Irinotecan—colon cancer	0.000812	0.00438	CcSEcCtD
Terazosin—Gastritis—Capecitabine—colon cancer	0.00081	0.00437	CcSEcCtD
Terazosin—Arrhythmia—Fluorouracil—colon cancer	0.00081	0.00437	CcSEcCtD
Terazosin—Back pain—Irinotecan—colon cancer	0.000797	0.0043	CcSEcCtD
Terazosin—Influenza—Capecitabine—colon cancer	0.000791	0.00427	CcSEcCtD
Terazosin—Asthma—Capecitabine—colon cancer	0.000791	0.00427	CcSEcCtD
Terazosin—Photosensitivity—Methotrexate—colon cancer	0.000776	0.00418	CcSEcCtD
Terazosin—Angina pectoris—Capecitabine—colon cancer	0.000771	0.00416	CcSEcCtD
Terazosin—Ill-defined disorder—Irinotecan—colon cancer	0.000764	0.00412	CcSEcCtD
Terazosin—Bronchitis—Capecitabine—colon cancer	0.000761	0.0041	CcSEcCtD
Terazosin—Vertigo—Vincristine—colon cancer	0.00076	0.0041	CcSEcCtD
Terazosin—Vision blurred—Fluorouracil—colon cancer	0.000744	0.00401	CcSEcCtD
Terazosin—Malaise—Irinotecan—colon cancer	0.000743	0.00401	CcSEcCtD
Terazosin—Vertigo—Irinotecan—colon cancer	0.00074	0.00399	CcSEcCtD
Terazosin—Dysuria—Capecitabine—colon cancer	0.00074	0.00399	CcSEcCtD
Terazosin—Syncope—Irinotecan—colon cancer	0.000739	0.00398	CcSEcCtD
Terazosin—Convulsion—Vincristine—colon cancer	0.000733	0.00395	CcSEcCtD
Terazosin—Loss of consciousness—Irinotecan—colon cancer	0.000724	0.0039	CcSEcCtD
Terazosin—Photosensitivity reaction—Capecitabine—colon cancer	0.000722	0.00389	CcSEcCtD
Terazosin—Myalgia—Vincristine—colon cancer	0.00072	0.00388	CcSEcCtD
Terazosin—Weight increased—Capecitabine—colon cancer	0.00072	0.00388	CcSEcCtD
Terazosin—Cough—Irinotecan—colon cancer	0.000719	0.00388	CcSEcCtD
Terazosin—Anaphylactoid reaction—Methotrexate—colon cancer	0.000704	0.0038	CcSEcCtD
Terazosin—Depression—Capecitabine—colon cancer	0.000703	0.00379	CcSEcCtD
Terazosin—Cerebrovascular accident—Methotrexate—colon cancer	0.000695	0.00375	CcSEcCtD
Terazosin—Discomfort—Irinotecan—colon cancer	0.000693	0.00374	CcSEcCtD
Terazosin—Anaphylactic shock—Vincristine—colon cancer	0.00069	0.00372	CcSEcCtD
Terazosin—Oedema—Vincristine—colon cancer	0.00069	0.00372	CcSEcCtD
Terazosin—Jaundice—Capecitabine—colon cancer	0.000688	0.00371	CcSEcCtD
Terazosin—Urinary tract infection—Capecitabine—colon cancer	0.000686	0.0037	CcSEcCtD
Terazosin—Conjunctivitis—Capecitabine—colon cancer	0.000686	0.0037	CcSEcCtD
Terazosin—Convulsion—Fluorouracil—colon cancer	0.000684	0.00369	CcSEcCtD
Terazosin—Osteoarthritis—Methotrexate—colon cancer	0.000682	0.00367	CcSEcCtD
Terazosin—Confusional state—Irinotecan—colon cancer	0.000678	0.00365	CcSEcCtD
Terazosin—Thrombocytopenia—Vincristine—colon cancer	0.000676	0.00364	CcSEcCtD
Terazosin—Oedema—Irinotecan—colon cancer	0.000672	0.00362	CcSEcCtD
Terazosin—Anaphylactic shock—Irinotecan—colon cancer	0.000672	0.00362	CcSEcCtD
Terazosin—Myalgia—Fluorouracil—colon cancer	0.000672	0.00362	CcSEcCtD
Terazosin—Chest pain—Fluorouracil—colon cancer	0.000672	0.00362	CcSEcCtD
Terazosin—Hyperhidrosis—Vincristine—colon cancer	0.000667	0.0036	CcSEcCtD
Terazosin—Epistaxis—Capecitabine—colon cancer	0.000665	0.00359	CcSEcCtD
Terazosin—Discomfort—Fluorouracil—colon cancer	0.000664	0.00358	CcSEcCtD
Terazosin—Shock—Irinotecan—colon cancer	0.000661	0.00357	CcSEcCtD
Terazosin—Thrombocytopenia—Irinotecan—colon cancer	0.000658	0.00355	CcSEcCtD
Terazosin—Anorexia—Vincristine—colon cancer	0.000658	0.00355	CcSEcCtD
Terazosin—Hyperhidrosis—Irinotecan—colon cancer	0.00065	0.0035	CcSEcCtD
Terazosin—Confusional state—Fluorouracil—colon cancer	0.000649	0.0035	CcSEcCtD
Terazosin—Hypotension—Vincristine—colon cancer	0.000645	0.00348	CcSEcCtD
Terazosin—Oedema—Fluorouracil—colon cancer	0.000644	0.00347	CcSEcCtD
Terazosin—Anaphylactic shock—Fluorouracil—colon cancer	0.000644	0.00347	CcSEcCtD
Terazosin—Anorexia—Irinotecan—colon cancer	0.000641	0.00346	CcSEcCtD
Terazosin—Rhinitis—Capecitabine—colon cancer	0.000635	0.00342	CcSEcCtD
Terazosin—Thrombocytopenia—Fluorouracil—colon cancer	0.00063	0.0034	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Vincristine—colon cancer	0.000629	0.00339	CcSEcCtD
Terazosin—Pharyngitis—Capecitabine—colon cancer	0.000629	0.00339	CcSEcCtD
Terazosin—Tachycardia—Fluorouracil—colon cancer	0.000628	0.00339	CcSEcCtD
Terazosin—Hypotension—Irinotecan—colon cancer	0.000628	0.00339	CcSEcCtD
Terazosin—Insomnia—Vincristine—colon cancer	0.000624	0.00337	CcSEcCtD
Terazosin—Oedema peripheral—Capecitabine—colon cancer	0.000624	0.00336	CcSEcCtD
Terazosin—Paraesthesia—Vincristine—colon cancer	0.00062	0.00334	CcSEcCtD
Terazosin—Anorexia—Fluorouracil—colon cancer	0.000614	0.00331	CcSEcCtD
Terazosin—Visual impairment—Capecitabine—colon cancer	0.00061	0.00329	CcSEcCtD
Terazosin—Insomnia—Irinotecan—colon cancer	0.000608	0.00328	CcSEcCtD
Terazosin—Paraesthesia—Irinotecan—colon cancer	0.000604	0.00325	CcSEcCtD
Terazosin—Hypotension—Fluorouracil—colon cancer	0.000602	0.00324	CcSEcCtD
Terazosin—Decreased appetite—Vincristine—colon cancer	0.0006	0.00324	CcSEcCtD
Terazosin—Dyspnoea—Irinotecan—colon cancer	0.000599	0.00323	CcSEcCtD
Terazosin—Somnolence—Irinotecan—colon cancer	0.000598	0.00322	CcSEcCtD
Terazosin—Fatigue—Vincristine—colon cancer	0.000595	0.00321	CcSEcCtD
Terazosin—Eye disorder—Capecitabine—colon cancer	0.000592	0.00319	CcSEcCtD
Terazosin—Dyspepsia—Irinotecan—colon cancer	0.000592	0.00319	CcSEcCtD
Terazosin—Tinnitus—Capecitabine—colon cancer	0.00059	0.00318	CcSEcCtD
Terazosin—Pain—Vincristine—colon cancer	0.00059	0.00318	CcSEcCtD
Terazosin—Constipation—Vincristine—colon cancer	0.00059	0.00318	CcSEcCtD
Terazosin—Asthma—Methotrexate—colon cancer	0.000589	0.00318	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000587	0.00316	CcSEcCtD
Terazosin—Decreased appetite—Irinotecan—colon cancer	0.000584	0.00315	CcSEcCtD
Terazosin—Insomnia—Fluorouracil—colon cancer	0.000582	0.00314	CcSEcCtD
Terazosin—Fatigue—Irinotecan—colon cancer	0.00058	0.00312	CcSEcCtD
Terazosin—Paraesthesia—Fluorouracil—colon cancer	0.000578	0.00312	CcSEcCtD
Terazosin—Constipation—Irinotecan—colon cancer	0.000575	0.0031	CcSEcCtD
Terazosin—Pain—Irinotecan—colon cancer	0.000575	0.0031	CcSEcCtD
Terazosin—Dyspnoea—Fluorouracil—colon cancer	0.000574	0.00309	CcSEcCtD
Terazosin—Somnolence—Fluorouracil—colon cancer	0.000572	0.00309	CcSEcCtD
Terazosin—Dyspepsia—Fluorouracil—colon cancer	0.000567	0.00306	CcSEcCtD
Terazosin—Arrhythmia—Capecitabine—colon cancer	0.000566	0.00305	CcSEcCtD
Terazosin—Gastrointestinal pain—Vincristine—colon cancer	0.000564	0.00304	CcSEcCtD
Terazosin—Decreased appetite—Fluorouracil—colon cancer	0.00056	0.00302	CcSEcCtD
Terazosin—Feeling abnormal—Irinotecan—colon cancer	0.000554	0.00299	CcSEcCtD
Terazosin—Malnutrition—Capecitabine—colon cancer	0.000551	0.00297	CcSEcCtD
Terazosin—Dysuria—Methotrexate—colon cancer	0.000551	0.00297	CcSEcCtD
Terazosin—Pain—Fluorouracil—colon cancer	0.000551	0.00297	CcSEcCtD
Terazosin—Gastrointestinal pain—Irinotecan—colon cancer	0.00055	0.00296	CcSEcCtD
Terazosin—Abdominal pain—Vincristine—colon cancer	0.000546	0.00294	CcSEcCtD
Terazosin—Body temperature increased—Vincristine—colon cancer	0.000546	0.00294	CcSEcCtD
Terazosin—Flatulence—Capecitabine—colon cancer	0.000543	0.00293	CcSEcCtD
Terazosin—Erectile dysfunction—Methotrexate—colon cancer	0.000542	0.00292	CcSEcCtD
Terazosin—Dysgeusia—Capecitabine—colon cancer	0.00054	0.00291	CcSEcCtD
Terazosin—Photosensitivity reaction—Methotrexate—colon cancer	0.000538	0.0029	CcSEcCtD
Terazosin—Back pain—Capecitabine—colon cancer	0.000533	0.00288	CcSEcCtD
Terazosin—Abdominal pain—Irinotecan—colon cancer	0.000531	0.00287	CcSEcCtD
Terazosin—Body temperature increased—Irinotecan—colon cancer	0.000531	0.00287	CcSEcCtD
Terazosin—Feeling abnormal—Fluorouracil—colon cancer	0.000531	0.00286	CcSEcCtD
Terazosin—Depression—Methotrexate—colon cancer	0.000524	0.00282	CcSEcCtD
Terazosin—Vision blurred—Capecitabine—colon cancer	0.00052	0.0028	CcSEcCtD
Terazosin—Tremor—Capecitabine—colon cancer	0.000517	0.00278	CcSEcCtD
Terazosin—Ill-defined disorder—Capecitabine—colon cancer	0.000512	0.00276	CcSEcCtD
Terazosin—Conjunctivitis—Methotrexate—colon cancer	0.00051	0.00275	CcSEcCtD
Terazosin—Body temperature increased—Fluorouracil—colon cancer	0.000509	0.00274	CcSEcCtD
Terazosin—Hypersensitivity—Vincristine—colon cancer	0.000509	0.00274	CcSEcCtD
Terazosin—Sweating—Methotrexate—colon cancer	0.000503	0.00271	CcSEcCtD
Terazosin—Malaise—Capecitabine—colon cancer	0.000497	0.00268	CcSEcCtD
Terazosin—Epistaxis—Methotrexate—colon cancer	0.000495	0.00267	CcSEcCtD
Terazosin—Vertigo—Capecitabine—colon cancer	0.000495	0.00267	CcSEcCtD
Terazosin—Hypersensitivity—Irinotecan—colon cancer	0.000495	0.00267	CcSEcCtD
Terazosin—Asthenia—Vincristine—colon cancer	0.000495	0.00267	CcSEcCtD
Terazosin—Syncope—Capecitabine—colon cancer	0.000494	0.00267	CcSEcCtD
Terazosin—Palpitations—Capecitabine—colon cancer	0.000487	0.00263	CcSEcCtD
Terazosin—Loss of consciousness—Capecitabine—colon cancer	0.000485	0.00261	CcSEcCtD
Terazosin—Asthenia—Irinotecan—colon cancer	0.000482	0.0026	CcSEcCtD
Terazosin—Cough—Capecitabine—colon cancer	0.000481	0.00259	CcSEcCtD
Terazosin—Hypersensitivity—Fluorouracil—colon cancer	0.000474	0.00256	CcSEcCtD
Terazosin—Diarrhoea—Vincristine—colon cancer	0.000472	0.00255	CcSEcCtD
Terazosin—Chest pain—Capecitabine—colon cancer	0.000469	0.00253	CcSEcCtD
Terazosin—Myalgia—Capecitabine—colon cancer	0.000469	0.00253	CcSEcCtD
Terazosin—Arthralgia—Capecitabine—colon cancer	0.000469	0.00253	CcSEcCtD
Terazosin—Pharyngitis—Methotrexate—colon cancer	0.000468	0.00252	CcSEcCtD
Terazosin—Anxiety—Capecitabine—colon cancer	0.000468	0.00252	CcSEcCtD
Terazosin—Discomfort—Capecitabine—colon cancer	0.000464	0.0025	CcSEcCtD
Terazosin—Diarrhoea—Irinotecan—colon cancer	0.00046	0.00248	CcSEcCtD
Terazosin—Dry mouth—Capecitabine—colon cancer	0.000459	0.00247	CcSEcCtD
Terazosin—Dizziness—Vincristine—colon cancer	0.000456	0.00246	CcSEcCtD
Terazosin—Pruritus—Fluorouracil—colon cancer	0.000456	0.00246	CcSEcCtD
Terazosin—Visual impairment—Methotrexate—colon cancer	0.000454	0.00245	CcSEcCtD
Terazosin—Confusional state—Capecitabine—colon cancer	0.000454	0.00245	CcSEcCtD
Terazosin—Oedema—Capecitabine—colon cancer	0.00045	0.00243	CcSEcCtD
Terazosin—Dizziness—Irinotecan—colon cancer	0.000445	0.0024	CcSEcCtD
Terazosin—Shock—Capecitabine—colon cancer	0.000443	0.00239	CcSEcCtD
Terazosin—Eye disorder—Methotrexate—colon cancer	0.000441	0.00238	CcSEcCtD
Terazosin—Diarrhoea—Fluorouracil—colon cancer	0.000441	0.00238	CcSEcCtD
Terazosin—Thrombocytopenia—Capecitabine—colon cancer	0.000441	0.00238	CcSEcCtD
Terazosin—Tinnitus—Methotrexate—colon cancer	0.00044	0.00237	CcSEcCtD
Terazosin—Tachycardia—Capecitabine—colon cancer	0.000439	0.00237	CcSEcCtD
Terazosin—Vomiting—Vincristine—colon cancer	0.000439	0.00237	CcSEcCtD
Terazosin—Rash—Vincristine—colon cancer	0.000435	0.00235	CcSEcCtD
Terazosin—Hyperhidrosis—Capecitabine—colon cancer	0.000435	0.00235	CcSEcCtD
Terazosin—Dermatitis—Vincristine—colon cancer	0.000435	0.00234	CcSEcCtD
Terazosin—Headache—Vincristine—colon cancer	0.000432	0.00233	CcSEcCtD
Terazosin—Anorexia—Capecitabine—colon cancer	0.000429	0.00231	CcSEcCtD
Terazosin—Vomiting—Irinotecan—colon cancer	0.000427	0.0023	CcSEcCtD
Terazosin—Dizziness—Fluorouracil—colon cancer	0.000426	0.0023	CcSEcCtD
Terazosin—Rash—Irinotecan—colon cancer	0.000424	0.00229	CcSEcCtD
Terazosin—Dermatitis—Irinotecan—colon cancer	0.000423	0.00228	CcSEcCtD
Terazosin—Headache—Irinotecan—colon cancer	0.000421	0.00227	CcSEcCtD
Terazosin—Hypotension—Capecitabine—colon cancer	0.00042	0.00227	CcSEcCtD
Terazosin—Malnutrition—Methotrexate—colon cancer	0.00041	0.00221	CcSEcCtD
Terazosin—Nausea—Vincristine—colon cancer	0.00041	0.00221	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00041	0.00221	CcSEcCtD
Terazosin—Vomiting—Fluorouracil—colon cancer	0.000409	0.00221	CcSEcCtD
Terazosin—Insomnia—Capecitabine—colon cancer	0.000407	0.00219	CcSEcCtD
Terazosin—Rash—Fluorouracil—colon cancer	0.000406	0.00219	CcSEcCtD
Terazosin—Dermatitis—Fluorouracil—colon cancer	0.000406	0.00219	CcSEcCtD
Terazosin—Paraesthesia—Capecitabine—colon cancer	0.000404	0.00218	CcSEcCtD
Terazosin—Headache—Fluorouracil—colon cancer	0.000403	0.00217	CcSEcCtD
Terazosin—Dysgeusia—Methotrexate—colon cancer	0.000402	0.00217	CcSEcCtD
Terazosin—Dyspnoea—Capecitabine—colon cancer	0.000401	0.00216	CcSEcCtD
Terazosin—Nausea—Irinotecan—colon cancer	0.000399	0.00215	CcSEcCtD
Terazosin—Back pain—Methotrexate—colon cancer	0.000397	0.00214	CcSEcCtD
Terazosin—Dyspepsia—Capecitabine—colon cancer	0.000396	0.00214	CcSEcCtD
Terazosin—Decreased appetite—Capecitabine—colon cancer	0.000391	0.00211	CcSEcCtD
Terazosin—Fatigue—Capecitabine—colon cancer	0.000388	0.00209	CcSEcCtD
Terazosin—Vision blurred—Methotrexate—colon cancer	0.000387	0.00209	CcSEcCtD
Terazosin—Pain—Capecitabine—colon cancer	0.000385	0.00207	CcSEcCtD
Terazosin—Constipation—Capecitabine—colon cancer	0.000385	0.00207	CcSEcCtD
Terazosin—Nausea—Fluorouracil—colon cancer	0.000382	0.00206	CcSEcCtD
Terazosin—Ill-defined disorder—Methotrexate—colon cancer	0.000381	0.00205	CcSEcCtD
Terazosin—Feeling abnormal—Capecitabine—colon cancer	0.000371	0.002	CcSEcCtD
Terazosin—Malaise—Methotrexate—colon cancer	0.00037	0.002	CcSEcCtD
Terazosin—Vertigo—Methotrexate—colon cancer	0.000369	0.00199	CcSEcCtD
Terazosin—Gastrointestinal pain—Capecitabine—colon cancer	0.000368	0.00198	CcSEcCtD
Terazosin—Cough—Methotrexate—colon cancer	0.000358	0.00193	CcSEcCtD
Terazosin—Abdominal pain—Capecitabine—colon cancer	0.000356	0.00192	CcSEcCtD
Terazosin—Body temperature increased—Capecitabine—colon cancer	0.000356	0.00192	CcSEcCtD
Terazosin—Convulsion—Methotrexate—colon cancer	0.000356	0.00192	CcSEcCtD
Terazosin—Arthralgia—Methotrexate—colon cancer	0.000349	0.00188	CcSEcCtD
Terazosin—Chest pain—Methotrexate—colon cancer	0.000349	0.00188	CcSEcCtD
Terazosin—Myalgia—Methotrexate—colon cancer	0.000349	0.00188	CcSEcCtD
Terazosin—Discomfort—Methotrexate—colon cancer	0.000345	0.00186	CcSEcCtD
Terazosin—Confusional state—Methotrexate—colon cancer	0.000338	0.00182	CcSEcCtD
Terazosin—Anaphylactic shock—Methotrexate—colon cancer	0.000335	0.00181	CcSEcCtD
Terazosin—Hypersensitivity—Capecitabine—colon cancer	0.000332	0.00179	CcSEcCtD
Terazosin—Thrombocytopenia—Methotrexate—colon cancer	0.000328	0.00177	CcSEcCtD
Terazosin—Hyperhidrosis—Methotrexate—colon cancer	0.000324	0.00175	CcSEcCtD
Terazosin—Asthenia—Capecitabine—colon cancer	0.000323	0.00174	CcSEcCtD
Terazosin—Anorexia—Methotrexate—colon cancer	0.000319	0.00172	CcSEcCtD
Terazosin—Pruritus—Capecitabine—colon cancer	0.000318	0.00172	CcSEcCtD
Terazosin—Hypotension—Methotrexate—colon cancer	0.000313	0.00169	CcSEcCtD
Terazosin—Diarrhoea—Capecitabine—colon cancer	0.000308	0.00166	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000305	0.00165	CcSEcCtD
Terazosin—Insomnia—Methotrexate—colon cancer	0.000303	0.00163	CcSEcCtD
Terazosin—Paraesthesia—Methotrexate—colon cancer	0.000301	0.00162	CcSEcCtD
Terazosin—Dyspnoea—Methotrexate—colon cancer	0.000299	0.00161	CcSEcCtD
Terazosin—Somnolence—Methotrexate—colon cancer	0.000298	0.00161	CcSEcCtD
Terazosin—Dizziness—Capecitabine—colon cancer	0.000298	0.0016	CcSEcCtD
Terazosin—Dyspepsia—Methotrexate—colon cancer	0.000295	0.00159	CcSEcCtD
Terazosin—Decreased appetite—Methotrexate—colon cancer	0.000291	0.00157	CcSEcCtD
Terazosin—Fatigue—Methotrexate—colon cancer	0.000289	0.00156	CcSEcCtD
Terazosin—Pain—Methotrexate—colon cancer	0.000286	0.00154	CcSEcCtD
Terazosin—Vomiting—Capecitabine—colon cancer	0.000286	0.00154	CcSEcCtD
Terazosin—Rash—Capecitabine—colon cancer	0.000284	0.00153	CcSEcCtD
Terazosin—Dermatitis—Capecitabine—colon cancer	0.000283	0.00153	CcSEcCtD
Terazosin—Headache—Capecitabine—colon cancer	0.000282	0.00152	CcSEcCtD
Terazosin—Feeling abnormal—Methotrexate—colon cancer	0.000276	0.00149	CcSEcCtD
Terazosin—Gastrointestinal pain—Methotrexate—colon cancer	0.000274	0.00148	CcSEcCtD
Terazosin—Nausea—Capecitabine—colon cancer	0.000267	0.00144	CcSEcCtD
Terazosin—Body temperature increased—Methotrexate—colon cancer	0.000265	0.00143	CcSEcCtD
Terazosin—Abdominal pain—Methotrexate—colon cancer	0.000265	0.00143	CcSEcCtD
Terazosin—Hypersensitivity—Methotrexate—colon cancer	0.000247	0.00133	CcSEcCtD
Terazosin—Asthenia—Methotrexate—colon cancer	0.00024	0.0013	CcSEcCtD
Terazosin—Pruritus—Methotrexate—colon cancer	0.000237	0.00128	CcSEcCtD
Terazosin—Diarrhoea—Methotrexate—colon cancer	0.000229	0.00124	CcSEcCtD
Terazosin—Dizziness—Methotrexate—colon cancer	0.000221	0.00119	CcSEcCtD
Terazosin—Vomiting—Methotrexate—colon cancer	0.000213	0.00115	CcSEcCtD
Terazosin—Rash—Methotrexate—colon cancer	0.000211	0.00114	CcSEcCtD
Terazosin—Dermatitis—Methotrexate—colon cancer	0.000211	0.00114	CcSEcCtD
Terazosin—Headache—Methotrexate—colon cancer	0.00021	0.00113	CcSEcCtD
Terazosin—Nausea—Methotrexate—colon cancer	0.000199	0.00107	CcSEcCtD
